Novel treatments using PD1 inhibitors for advanced and metastatic cutaneous squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel treatments using PD1 inhibitors for advanced and metastatic cutaneous squamous cell carcinoma

Published:2020-09-16 Issue:10 Volume:20 Page:819-822
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Pezeshki Saharnaz¹²,Hemmati Sara¹²,Rezaei Nima³⁴⁵

Affiliation:

1. Cancer Immunology Project Interest Group (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran

2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

3. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

5. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2020.1812389

Reference48 articles.

1. Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

2. Phase II and Biologic Study of Interferon Alfa, Retinoic Acid, and Cisplatin in Advanced Squamous Skin Cancer

3. Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial

4. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

5. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Squamous Cell Carcinoma with Signet-Ring Cell Component and CDX2 Expression in a Patient Treated with PD-1 Inhibitor: A Case Report of a Common Tumor with Unusual Differentiation;Case Reports in Pathology;2023-02-09

2. PD-1 Blockade With Concurrent Radiotherapy for Locally Advanced Inoperable Cutaneous Squamous Cell Carcinoma;Journal of Cutaneous Medicine and Surgery;2021-12-04

3. Hide‐and‐seek: Neurotropic squamous cell carcinoma of the periorbital region – a series of five cases and review of the literature;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-11

4. Hide‐and‐seek: Neurotropes Plattenepithelkarzinom der periorbitalen Region – eine Fallserie und Übersichtsarbeit aktueller Literatur;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-11

5. Grzybowski’s Generalized Eruptive Keratoacanthomas in a Patient with Terminal Kidney Disease—An Unmet Medical Need Equally Ameliorated by Topical Imiquimod Cream and Lapacho Tea Wraps: A Case Report;Dermatology and Therapy;2021-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3